PainChek General Discussion, page-15015

Just have a look at Phillip Daffas' career history on linkedin.
I agree its all potential but deals at the scale he's working on don't happen overnight.
It depends on your appetite for risk, I suspect there are a lot of people on the sidelines waiting for concrete deals and revenue before jumping in - and happy to pay a higher price per share with less risk - which is a sound tactic.
I'm expecting when this happens at some stage this year or early 2021 FOMO will kick in and it'll jump rapidly - and maybe run too far on hype.

Dementia - Aged Care Sector
Phillips/Siemens - Hospital Market
Home Care
UK / PCS growth
FDA Approval
Baby App
Delirium Market


I'm not up ramping - the above is directly from the CEO - and he's the quiet reserved type, they signed up 54 new aged homes recently and announced it on social media - not even an ASX ann.

That's just the stuff we know about, 1% of all the above markets in 5 years time is easy $5 a share.
Interestingly in what I've read of the Patents, there was a lot around pain assessment during drug trials and monitoring the reaction to drugs - who knows where that could go.

So essentially it's about whether PCK is different to all the other small caps with massive plans and potential.

I think they are, it won't be this year, but I'm happy to wait and enjoy the process. They are also helping people in pain, improving health care, it's not a bad stock to be in.